Celldex Therapeutics Correlations

Stocks . USA . 
Stock . Celldex Therapeutics
CLDX Stock  USD 25.39  0.26  1.01%   
The current 90-days correlation between Celldex Therapeutics and Fate Therapeutics is 0.3 (i.e., Weak diversification). The correlation of Celldex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Celldex Therapeutics Correlation With Market

Significant diversification

The correlation between Celldex Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.

Moving together with Celldex Stock

  0.79ME 23Andme HoldingPairCorr
  0.63DOMH Dominari HoldingsPairCorr
  0.67DRMA Dermata TherapeuticsPairCorr
  0.83VINC Vincerx PharmaPairCorr
  0.65VRCA Verrica PharmaceuticalsPairCorr

Moving against Celldex Stock

  0.75DRUG Bright Minds BiosciencesPairCorr
  0.65SABSW SAB BiotherapeuticsPairCorr
  0.59VCEL Vericel Corp OrdPairCorr
  0.52VANI Vivani MedicalPairCorr
  0.52VCYT VeracytePairCorr
  0.5DSGN Design TherapeuticsPairCorr
  0.41VERV Verve TherapeuticsPairCorr
  0.38CDIOW Cardio DiagnosticsPairCorr
  0.37DRTS Alpha Tau MedicalPairCorr
  0.36DMAC DiaMedica TherapeuticsPairCorr
  0.74VRNA Verona Pharma PLCPairCorr
  0.72VYNE Vyne Therapeutics TrendingPairCorr
  0.64DVAX Dynavax TechnologiesPairCorr
  0.63VSTM VerastemPairCorr
  0.58VTRS ViatrisPairCorr
  0.47VTVT vTv TherapeuticsPairCorr
  0.41DYAI Dyadic InternationalPairCorr
  0.38KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Celldex Stock performing well and Celldex Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celldex Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Celldex Therapeutics Corporate Management

Ronald PepinChief Bus. Officer and Sr. VPProfile
Patrick TillSenior CommunicationsProfile
Prof SchlessingerCoFounder BoardProfile
Diane MDSenior OfficerProfile
Margo MDSenior AffairsProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY